UBS Group Issues Pessimistic Forecast for AdaptHealth (NASDAQ:AHCO) Stock Price

AdaptHealth (NASDAQ:AHCO) had its target price decreased by analysts at UBS Group from $10.00 to $9.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. UBS Group‘s price objective indicates a potential upside of 23.12% from the company’s previous close.

Other analysts have also recently issued research reports about the company. Truist Financial dropped their price objective on AdaptHealth from $14.00 to $9.00 and set a “buy” rating on the stock in a report on Wednesday, August 5th. Robert W. Baird dropped their price objective on AdaptHealth from $10.00 to $9.00 and set an “outperform” rating for the company in a research note on Thursday, September 17th. Weiss Ratings restated a “sell (d)” rating on shares of AdaptHealth in a research report on Wednesday, August 19th. Royal Bank Of Canada reduced their target price on AdaptHealth from $15.00 to $8.00 and set an “outperform” rating for the company in a research report on Thursday, August 6th. Finally, Jefferies Financial Group raised AdaptHealth from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $11.00 to $13.00 in a report on Tuesday, July 21st. Seven analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, AdaptHealth presently has an average rating of “Moderate Buy” and an average price target of $10.00.

AdaptHealth Stock Performance

NASDAQ:AHCO traded up $1.03 on Wednesday, reaching $7.31. 6,327,405 shares of the company’s stock were exchanged, compared to its average volume of 1,945,419. The stock has a fifty day simple moving average of $5.90 and a 200-day simple moving average of $9.12. AdaptHealth has a 52 week low of $5.21 and a 52 week high of $13.43. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.12 and a quick ratio of 0.98. The firm has a market cap of $996.65 million, a price-to-earnings ratio of -4.27 and a beta of 1.36.

AdaptHealth (NASDAQ:AHCO) last announced its quarterly earnings results on Tuesday, November 3rd. The company reported ($1.13) EPS for the quarter, missing analysts’ consensus estimates of ($0.05) by ($1.08). The business had revenue of $745.65 million for the quarter, compared to analysts’ expectations of $725.87 million. AdaptHealth had a negative net margin of 7.07% and a positive return on equity of 3.36%. The business’s quarterly revenue was down 9.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.16 earnings per share.

Insiders Place Their Bets

In other AdaptHealth news, Director Kenneth Samet purchased 23,500 shares of the business’s stock in a transaction on Thursday, August 6th. The stock was acquired at an average cost of $6.38 per share, for a total transaction of $149,930.00. Following the completion of the transaction, the director directly owned 48,569 shares in the company, valued at approximately $309,870.22. This represents a 93.74% increase in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 1.95% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Fulcrum Asset Management LLP grew its holdings in AdaptHealth by 526.4% in the 3rd quarter. Fulcrum Asset Management LLP now owns 24,456 shares of the company’s stock worth $139,000 after acquiring an additional 20,552 shares during the last quarter. Brickley Wealth Management bought a new stake in shares of AdaptHealth in the third quarter worth about $56,000. Brighton Jones LLC purchased a new position in AdaptHealth during the 3rd quarter valued at about $125,000. Chicago Partners Investment Group LLC bought a new position in AdaptHealth during the 3rd quarter valued at approximately $118,000. Finally, State of Wyoming lifted its holdings in AdaptHealth by 126.4% in the 3rd quarter. State of Wyoming now owns 51,913 shares of the company’s stock worth $293,000 after buying an additional 28,988 shares during the period. Institutional investors own 82.67% of the company’s stock.

Trending Headlines about AdaptHealth

Here are the key news stories impacting AdaptHealth this week:

• Positive Sentiment: AdaptHealth raised its 2026 adjusted EBITDA guidance to $510 million–$525 million and outlined a path to a 20% margin on its largest capitated contract by Q4 2027. The improved outlook and potential contract profitability are positive signals for investors. AdaptHealth margin and outlook article
• Positive Sentiment: Third-quarter revenue of $745.65 million topped analysts’ $725.87 million estimate, providing a bright spot in the earnings report. Third-quarter results
• Neutral Sentiment: The company will participate in the UBS Global Healthcare Conference on November 10. The event may provide investors with further details, but the announcement itself does not indicate a change in business performance. Investor conference announcement
• Negative Sentiment: AdaptHealth reported a third-quarter loss of $1.13 per share, substantially worse than the $0.05 loss analysts expected. Revenue was also down 9.1% year over year, highlighting ongoing performance challenges despite the estimate beat. Quarterly earnings report

AdaptHealth Company Profile

AdaptHealth Corp. (NASDAQ: AHCO) is a provider of home medical equipment, supplies and related healthcare services in the United States. The company helps patients manage chronic conditions and recover from illness or injury outside of traditional healthcare facilities, working with individuals, caregivers, physicians and payers.

Its products and services include respiratory equipment and supplies, oxygen therapy, sleep therapy devices such as continuous positive airway pressure systems, diabetes management products, mobility and accessibility equipment, and other durable medical equipment.